Associated Papers
Two HIV-1 variants resistant to small molecule CCR5 inhibitors differ in how they use CCR5 for entry.
Berro R et al.
Plos Pathogens, 2009
Structural basis for the interaction of CCR5 with a small molecule, functionally selective CCR5 agonist.
Saita Y et al.
Journal of Immunology (baltimore, Md. : 1950), 2006
The differential sensitivity of human and rhesus macaque CCR5 to small-molecule inhibitors of human immunodeficiency virus type 1 entry is explained by a single amino acid difference and suggests a mechanism of action for these inhibitors.
Billick E et al.
Journal of Virology, 2004
A critical site in the core of the CCR5 chemokine receptor required for binding and infectivity of human immunodeficiency virus type 1.
Siciliano SJ et al.
The Journal of Biological Chemistry, 1999
Polymorphisms in the CCR5 genes of African green monkeys and mice implicate specific amino acids in infections by simian and human immunodeficiency viruses.
Kuhmann SE et al.
Journal of Virology, 1997
Parallel evolution of CCR5-null phenotypes in humans and in a natural host of simian immunodeficiency virus.
Palacios E et al.
Current Biology : Cb, 0
Select a paper to view details